Zobrazeno 1 - 7
of 7
pro vyhledávání: '"MESH: Breast Neoplasms / genetics"'
Autor:
Jane E. Aubin, Geoffrey Vargas, Edith Bonnelye, Sophie Vacher, Marie Brevet, Pascal Reboul, M Filipits, Ivan Bièche, C Boyault, W Jacot, Lamia Bouazza, Sandra Geraci, Keltouma Driouch, Francesco Pantano, Michael Gnant, Catherine Alix-Panabières, M Gervais, Laure Cayrefourcq, Philippe Clézardin, M Bouchet, M Mazel, Martine Croset, Claire Benetollo, C Kan, Martine Duterque-Coquillaud
Publikováno v:
Oncogene
Oncogene, Nature Publishing Group, 2019, 38 (7), pp.950-964. ⟨10.1038/s41388-018-0579-3 ⟩
Oncogene, Nature Publishing Group, 2019, 38 (7), pp.950-964. ⟨10.1038/s41388-018-0579-3⟩
Oncogene, 2019, 38 (7), pp.950-964. ⟨10.1038/s41388-018-0579-3⟩
Oncogene, Nature Publishing Group, 2019, 38 (7), pp.950-964. ⟨10.1038/s41388-018-0579-3 ⟩
Oncogene, Nature Publishing Group, 2019, 38 (7), pp.950-964. ⟨10.1038/s41388-018-0579-3⟩
Oncogene, 2019, 38 (7), pp.950-964. ⟨10.1038/s41388-018-0579-3⟩
International audience; Bone is the most common metastatic site for breast cancer. Estrogen-related-receptor alpha (ERRα) has been implicated in cancer cell invasiveness. Here, we established that ERRα promotes spontaneous metastatic dissemination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::673afe46894df907867170c048c800d7
http://hdl.handle.net/20.500.12210/55264
http://hdl.handle.net/20.500.12210/55264
Autor:
Sonia Abdelhak, Hamouda Boussen, Olfa Messaoud, Mohamed Samir Boubaker, Majdi Nagara, Mariem Ben Rekaya, Amel Benammar Elgaaied, Lotfi Chouchane, Shan Jingxuan, Lilia Romdhane, Yosr Hamdi, Ridha Mrad
Publikováno v:
BMC Cancer
BMC Cancer, BioMed Central, 2018, 18 (1), pp.1295. ⟨10.1186/s12885-018-5133-8⟩
BMC Cancer, Vol 18, Iss 1, Pp 1-14 (2018)
BMC Cancer, BioMed Central, 2018, 18 (1), pp.1295. ⟨10.1186/s12885-018-5133-8⟩
BMC Cancer, Vol 18, Iss 1, Pp 1-14 (2018)
Background Breast cancer is the most common cancer in women worldwide. Around 50% of breast cancer familial risk has been so far explained by known susceptibility alleles with variable levels of risk and prevalence. The vast majority of these breast
Autor:
Stephen P. Jackson, Mareike Herzog, Alejandra Bruna, Luca Pellegrini, Violeta Serra, Mark J. O'Connor, Zhongwu Lai, Chloé Lescale, Jacqueline J.L. Jacobs, Fengtang Yang, Jonathan Lam, Matylda Sczaniecka-Clift, Abigail Shea, Carlos Caldas, Matthias Ostermaier, Gabriel Balmus, Julia Coates, Wenming Wei, Inge de Krijger, Yaron Galanty, Mukerrem Demir, Ludovic Deriano, Petra Beli, Domenic Pilger, Harveer Dev, Rimma Belotserkovskaya, Alistair Martin, Beiyuan Fu, Ting-Wei Will Chiang, Qian Wu
Publikováno v:
Nature Cell Biology
Nature Cell Biology, 2018, 20 (8), pp.954-965. ⟨10.1038/s41556-018-0140-1⟩
Nature cell biology
Nature Cell Biology, Nature Publishing Group, 2018, 20 (8), pp.954-965. ⟨10.1038/s41556-018-0140-1⟩
Nature Cell Biology, 2018, 20 (8), pp.954-965. ⟨10.1038/s41556-018-0140-1⟩
Nature cell biology
Nature Cell Biology, Nature Publishing Group, 2018, 20 (8), pp.954-965. ⟨10.1038/s41556-018-0140-1⟩
International audience; BRCA1 deficiencies cause breast, ovarian, prostate and other cancers, and render tumours hypersensitive to poly(ADP-ribose) polymerase (PARP) inhibitors. To understand the resistance mechanisms, we conducted whole-genome CRISP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94c03882fb1aad0056e71d15c34e8ed4
https://www.repository.cam.ac.uk/handle/1810/282947
https://www.repository.cam.ac.uk/handle/1810/282947
Autor:
Dumortier, Mandy, Ladam, Franck, Damour, Isabelle, Vacher, Sophie, Bièche, Ivan, Marchand, Nathalie, De Launoit, Yvan, Tulasne, David, Chotteau-Lelièvre, Anne
Publikováno v:
Breast Cancer Research
Breast Cancer Research, 2018, 20 (1), pp.73. ⟨10.1186/s13058-018-0992-0⟩
Breast Cancer Research, BioMed Central, 2018, 20, ⟨10.1186/s13058-018-0992-0⟩
Breast Cancer Research, BioMed Central, 2018, 20 (1), pp.73. ⟨10.1186/s13058-018-0992-0⟩
Breast Cancer Research, Vol 20, Iss 1, Pp 1-18 (2018)
Breast Cancer Research : BCR
Breast Cancer Research, BioMed Central, 2018, 20 (1), ⟨10.1186/s13058-018-0992-0⟩
Breast Cancer Research, 2018, 20 (1), pp.73. ⟨10.1186/s13058-018-0992-0⟩
Breast Cancer Research, BioMed Central, 2018, 20, ⟨10.1186/s13058-018-0992-0⟩
Breast Cancer Research, BioMed Central, 2018, 20 (1), pp.73. ⟨10.1186/s13058-018-0992-0⟩
Breast Cancer Research, Vol 20, Iss 1, Pp 1-18 (2018)
Breast Cancer Research : BCR
Breast Cancer Research, BioMed Central, 2018, 20 (1), ⟨10.1186/s13058-018-0992-0⟩
Background The ETS transcription factor ETV4 is involved in the main steps of organogenesis and is also a significant mediator of tumorigenesis and metastasis, such as in breast cancer. Indeed, ETV4 is overexpressed in breast tumors and is associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c1bdbc6fa24e5fe30ccd6083e8937deb
https://hal.science/hal-02391607
https://hal.science/hal-02391607
Autor:
Hanene Chelbi, Ahmed Baligh Laaribi, Refaat Sebai, Amel Mezlini, Hamza Ben Yahia, Amna Ben Hassine, Olfa Dziri, Nour Zidi, Wafa Babay, Nadia Boujelebene, Hela Rifi, Inès Zidi
Publikováno v:
Immunologic Research
Immunologic Research, Humana Press, 2016, ⟨10.1007/s12026-015-8782-6⟩
Immunologic Research, Humana Press, 2016, 64 (4), pp.961-968. ⟨10.1007/s12026-015-8782-6⟩
Immunologic Research, Humana Press, 2016, ⟨10.1007/s12026-015-8782-6⟩
Immunologic Research, Humana Press, 2016, 64 (4), pp.961-968. ⟨10.1007/s12026-015-8782-6⟩
International audience; HLA-G is highly expressed in cancer. Also, it is associated to its progression. Here, we explored the relationship between two HLA-G polymorphisms with breast cancer (BC) and tried to make a correlation with sHLA-G levels. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5590c2441f7b39f4a495010b27d75cf
https://hal-riip.archives-ouvertes.fr/pasteur-01400585/document
https://hal-riip.archives-ouvertes.fr/pasteur-01400585/document
Autor:
Chalabi, Nasséra, Bernard-Gallon, Dominique J, Bignon, Yves Jean, Kwiatkowski, Fabrice G, Agier, M, Vidal, V., Laplace-Chabaud, V, Sylvain-Vidal, Valérie, Bertholet, Vincent, De Longueville, Françoise, Lacroix, Marc, Leclercq, Guy, Remacle, Josè A, Sibille, Catherine, Zammateo, N, Ben Jaafar, N, Sefiani, Abdelaziz, Ouldim, Karim, Mégarbané, André, Jalkh, Nadine, Mahfoudh, Wijden, Troudi, Wafa, Ben Ammar-El Gaïed, A., Chouchane, Lotfi
Publikováno v:
Cancer Genomics and Proteomics
Cancer Genomics and Proteomics, International Institute of Anticancer Research, 2008, 5 (5), pp.253-61
Cancer Genomics and Proteomics, International Institute of Anticancer Research, 2008, 5 (5), pp.253-61
Erratum in :Cancer Genomics Proteomics. 2008 Nov-Dec;5(6):353.Cancer Genomics Proteomics. 2009 Jan-Feb;6(1):73.; International audience; BACKGROUND: In Western countries, breast cancer incidence and mortality are higher than in Mediterranean countrie
Publikováno v:
International Journal of Cancer
International Journal of Cancer, Wiley, 2007, 121 (5), pp.1036-1046. ⟨10.1002/ijc.22775⟩
International Journal of Cancer, 2007, 121 (5), pp.1036-1046. ⟨10.1002/ijc.22775⟩
International Journal of Cancer, Wiley, 2007, 121 (5), pp.1036-1046. ⟨10.1002/ijc.22775⟩
International Journal of Cancer, 2007, 121 (5), pp.1036-1046. ⟨10.1002/ijc.22775⟩
International audience; Malignant effusion in invasive breast carcinoma is associated with poor prognosis. To decipher molecular events leading to metastasis and to identify reliable markers for targeted therapies are of crucial need. Therefore, we h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8723c89629ba5ac3f716d3e1eaed227
https://hal-pasteur.archives-ouvertes.fr/pasteur-02872818
https://hal-pasteur.archives-ouvertes.fr/pasteur-02872818